hPRL-G129R

N/A

Report date: 2025/05/14 14:16:36

Base Information

Drug NamehPRL-G129R
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionApoptosis stimulantsProlactin receptor antagonists
TargetsProlactin receptor
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesClemson UniversityGreenville Hospital System
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesClemson UniversityGreenville Hospital System
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A